Skip to main content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

CDC Estimates 1.4 Million ED Visits/Year for Those Experiencing Homelessness

WEDNESDAY, June 12, 2024 -- During 2016 to 2021, an estimated 1.4 million emergency department visits were made per year among people experiencing...

Machine Translations Similar to Professionals for Spanish, Portuguese Discharge Instructions

WEDNESDAY, June 12, 2024 -- For Spanish and Portuguese, machine translation platforms have comparable performance to professional translations for discharge...

Exposure to Depressive Symptoms Linked to Worse Cognitive Function

WEDNESDAY, June 12, 2024 -- Exposure to elevated depressive symptoms starting in young adulthood is associated with worse cognitive function over midlife...

Sedentary Behaviors, Especially TV, Tied to Lower Odds of Healthy Aging

WEDNESDAY, June 12, 2024 -- Sedentary behaviors, especially watching television, are associated with reduced odds of healthy aging, according to a study...

Adverse Social Determinants of Health Linked to Prediabetes in Teens

WEDNESDAY, June 12, 2024 -- Adverse social determinants of health (SDOH) are associated with higher prevalence of prediabetes among adolescents, according to...

9/11 Responders May Face Higher Odds for Dementia

WEDNESDAY, June 12, 2024 -- After helping America through one of its worst tragedies, some responders to the events of 9/11 may now face another foe...

Dad Plays Role in His Infant's Microbiome

WEDNESDAY, June 12, 2024 -- Dads appear to make a small but important contribution to a newborn baby’s gut health, a new study discovers. Many microbes...

Biden Administration Pushes for Rule Wiping Medical Debt From Credit Reports

WEDNESDAY, June 12, 2024 -- In an effort to keep medical debt from destroying credit scores, the Biden administration announced Tuesday that it is moving ahead...

More Sickened After Eating Diamond Shruumz Bars, Cones and Gummies

WEDNESDAY, June 12, 2024 -- The number of people severely sickened after consuming mushroom edibles sold as Diamond Shruumz-brand Chocolate Bars, Cones or...

Exercise at One Time of Day Might Be Best for Blood Sugar Control

WEDNESDAY, June 11, 2024 -- Folks trying to control their blood sugar levels might do best to work out in the evening, a new study suggests. Exercise...

FDA Approves Kevzara (sarilumab) for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)

TARRYTOWN, N.Y. and CAMBRIDGE, MA, June 11, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the...

FDA Approves Expanded Age Indication for GSK’s Arexvy, the First Respiratory Syncytial Virus (RSV) Vaccine for Adults Aged 50-59 at Increased Risk

Philadelphia, PA June 07 2024 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory...

FDA Grants Accelerated Approval to Iqirvo (elafibranor) for the Treatment of Primary Biliary Cholangitis

PARIS, FRANCE, 10 June 2024: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated...

FDA Approves Rytelo (imetelstat) for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia

FOSTER CITY, Calif.--(BUSINESS WIRE) June 6, 2024 -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by...

FDA Approves mRESVIA (respiratory syncytial virus vaccine) for Prevention of Lower Respiratory Tract Disease Caused by RSV

CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA...

U.S. FDA Acknowledges Astellas' Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date

TOKYO, May 30, 2024 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug...

Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon PTH for Adults with Hypoparathyroidism

COPENHAGEN, Denmark, May 14, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food and Drug Administration (FDA)...

Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem

DUBLIN, Ireland and CHICAGO, April 29, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company...

Abeona Therapeutics Provides Regulatory Update on Pz-cel

CLEVELAND, April 22, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced a regulatory update for prademagene zamikeracel (pz-cel)...

Supernus Provides Regulatory Update for SPN-830

ROCKVILLE, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and...

"Self-Taught" AI Tool Helps to Diagnose and Predict Severity of Common Lung Cancer

NEW YORK, June 11, 2024. A computer program based on data from nearly a half-million tissue images and powered by artificial intelligence can accurately...

Alzheimer's drug discovery foundation's statement on FDA advisory committee's endorsement of donanemab

NEW YORK, June 10, 2024. Today, the FDA Peripheral and Central Nervous System Drugs Advisory Committee unanimously voted that donanemab shows clinical benefit...

Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials

DURHAM, N.C. and BEIJING, June 7, 2024. Brii Biosciences Limited ("Brii Bio," "we," or the "Company"), a biotechnology company developing therapies to improve...

AbbVie Announces Positive Topline Results from Phase 2 Trial Evaluating Elahere for High Folate Receptor-Alpha Expressing Platinum-Sensitive Ovarian Cancer

NORTH CHICAGO, Ill., June 6, 2024. AbbVie announced today positive topline results from the Phase 2 PICCOLO trial evaluating investigational mirvetuximab...

Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA

FOSTER CITY, Calif.--(BUSINESS WIRE) June 06, 2024 -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced data from the Phase 2b MYR204 open-label study...

Browse by news type

Drugs.com Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

Disclaimer

This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.